News

ASCO issues to-do list on tobacco control


 

FROM THE JOURNAL OF CLINICAL ONCOLOGY

But there was a significant drop off when it came to following up with treatment options. Only 44% routinely discuss medication options and only 39% provide other cessation support. The respondents cited inadequate training in tobacco cessation interventions and patient resistance as some of the barriers.

Dr. Hudis said sometimes tobacco cessation falls through the cracks for busy physicians. "That just reminds us that everyone in health care is stretched these days, working hard and balancing priorities," he said. "We just have to make sure that this remains front and center."

For its part, ASCO plans to help develop cessation tools and resources for providers to integrate into their practices. ASCO is also calling for a stronger focus on tobacco cessation both in medical training and continuing medical education courses. The organization is encouraging credentialing organizations to include questions about tobacco-dependence treatment in their exams. ASCO plans to partner with the American Board of Internal Medicine to make sure there is tobacco cessation content in the oncology specialty training boards.

mschneider@frontlinemedcom.com

©thinkstockphotos.com

The American Society of Clinical Oncology is calling for officials to beef up the regulation of tobacco products, increase research funding, and ensure widespread access to cessation treatments.

Pages

Recommended Reading

Androgen deprivation therapy linked to acute kidney injury
MDedge Hematology and Oncology
High-risk smokers benefit most from CT screening for lung cancer
MDedge Hematology and Oncology
Cancer survivors may have lower Alzheimer’s risk
MDedge Hematology and Oncology
Radium-223 prolongs survival in metastatic prostate cancer
MDedge Hematology and Oncology
Khorana score tracks risk of cancer death
MDedge Hematology and Oncology
No increased cancer risk in children born after assisted conception
MDedge Hematology and Oncology
Racial disparities found in thyroid cancer care
MDedge Hematology and Oncology
Racial discrepancy in breast cancer survival examined
MDedge Hematology and Oncology
Stem cell mutations in breast cancer may confer metastatic risk
MDedge Hematology and Oncology
Guidelines issued on radiation-induced heart disease
MDedge Hematology and Oncology